Pickering Energy Partners Acted as Co-Manager on LandBridge IPO
Pickering Energy Partners Acted as Co-Manager on LandBridge IPO
Pickering Energy Partners (“PEP”) acted as a co-manager on the initial public offering of 14,500,000 Class A shares for LandBridge Company LLC (NYSE: LB) which closed on July 1, 2024.
About Pickering Energy Partners
Pickering Energy Partners (PEP) is an energy-focused financial services platform. Our expertise spans decades across the entire energy landscape. We are, at our core, trusted energy advisors, investors, and partners alongside our clients. The PEP platform includes Investment Banking, Capital Markets, Investments, Research, and Consulting. Headquartered in Houston, Texas, PEP delivers an experienced, opportunistic team that aims to provide guidance and long-term value for clients while having a positive impact on the companies and communities that PEP invests in.
For more information, please visit www.PickeringEnergyPartners.com.
Pickering Energy Partners LP (“PEP”) is a SEC Registered Investment Adviser. Affiliated PEP Advisory LLC (“PEP BD”) is a registered broker-dealer, member FINRA/SIPC.
Josh Martin, Managing Director
jmartin@pepadvisory.com
+1.713.955.5338
For media inquiries:
Jennifer Petree / Kiara Jacobs
pr@petreepartners.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240709307754/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks